Title: A Comparative Study of Perinatal Safety and Antihypertensive Efficacy of Methyldopa and Labetalol in Treatment of Hypert- Ension in Pregnancy

Authors: Dr Sony Khedia, Dr Barkha Gurjar, Dr R.P. Rawat

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i5.70

Abstract

Introduction

Hypertensive disorders are the most common medical complications of pregnancy and are an important cause of maternal and perinatal morbid-dity worldwide1. These include preeclampsia and eclampsia.

Gestational hypertension is defined as de novo rise in BP >140/90mmHg after mid pregnancy (20weeks) and distinguished from preeclampsia by the absence of proteinuria. Gestational hypertension is termed transient hypertension if preeclampsia does not develop and blood pressure has returned to normal by 12 weeks postpartum. It is considered mild when BP>140/90 mm Hg and severe when BP>160/110 mm Hg2.

References

1.      National high blood pressure Education Program Working Group report on high blood pressure in pregnancy. Am. J. Obstet. Gynecol. 1990; 163; 1691-712.

2.      Sibai B.M., Diagnosis and management of gestational hypertension and preeclampsia. Obst Gyneol. 2003; 102: 18,192.

3.      Chesley L.C. Diagnosis of preeclampsia. Obstet Gynecol., 65: 423, 1985.

4.      Roberts J.M. Endothelial dysfunction in preeclampsia. Semen reprod. Endocrinol. 1989,16 : 5-15.

5.      Rubin P.C. Clin obstet Gynecol. 1986 jun; 13(2): 307-17.

6.      Armstrong P. Br. J. Hosp. Med. 1986 Nov., 36(5): 347-53.

7.      Wallin JD, Willson D, Winer N et al. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long term, double blind multicenter trial. Am. J. Med. 1983 oct. 17; 75(4A): 87-94.

8.      Plouin PF, Breat G, comparison of anti-hypertensive efficacy and perinatal safety of labetalol and methyldopa in treatment of hypertension in pregnancy: a randomized control trial. Br. J. Obstet Gynaecol, 1988 Sep; 95 (9): 868-76.

9.      Pickles CJ, Symonds EM, Broughton Pipkin F. The fetal outcome in a randomized double blind controlled trial of labetalol versus placebo in pregnancy induced hypertension. Br. J. Obstet Gynaecol, 1989 Jan; 96(1): 38-43.

10.  AM El. Qarmalawi, Morsy AH, Al-Fadly, Obeid Hashem M. Labetalol vs. Methyldopa in the treatment of pregnancy induced hypertension. Int. J. Gynecol Obstet 49, 1995: 125-130.

Corresponding Author

Dr Sony Khedia

Assistant Prof. (Obg & Gynae) GMC Kota